Modern insights into ophthalmic manifestations of rheumatic diseases

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

This literature review is devoted to the analysis of modern insights into ophthalmological manifestations (according to the data of foreign scientific literature in the PubMed system for 2017–2020) of the most common rheumatic diseases (rheumatoid arthritis, ankylosing spondylitis, systemic lupus erythematosus, systemic scleroderma, systemic vasculitis), which are characterized by damage to all structures of the eye and its adnexa: eyelids, orbital tissues, eyeball tunics, vessels, optic nerve and vitreous. Ocular lesion may be an onset, one of the diagnostic signs, or a biomarker of underlying medical condition.

Full Text

Restricted Access

About the authors

Daria A. Karpova

Tyumen State Medical University

Author for correspondence.
Email: karpovadaria9@gmail.com
SPIN-code: 5314-6638

clinical resident

Russian Federation, 54 Odesskaya str., Tyumen, 625023

Ekaterina E. Savina

Tyumen State Medical University

Email: katjushasav@rambler.ru

postgraduate student

Russian Federation, 54 Odesskaya str., Tyumen, 625023

Maria N. Ponomareva

Tyumen State Medical University

Email: mariyponomareva@yandex.ru
ORCID iD: 0000-0001-6522-3342
SPIN-code: 6631-8206

Dr. Sci. (Med.)

Russian Federation, 54 Odesskaya str., Tyumen, 625023

Yulia A. Lushpaeva

Tyumen State Medical University

Email: lushpaevay@mail.ru
ORCID iD: 0000-0003-4616-1259

Cand. Sci. (Med.), Associate Professor

Russian Federation, 54 Odesskaya str., Tyumen, 625023

Irina M. Partikeeva

Tyumen State Medical University

Email: I.Patrikeeva@tokb.ru
ORCID iD: 0000-0003-0530-0080

Head of the Rheumatology Department

Russian Federation, 54 Odesskaya str., Tyumen, 625023

References

  1. Pathak S, McDermott MF, Savic S. Autoinflammatory diseases: update on classification diagnosis and management. J Clin Pathol. 2017;70(1):1–8. doi: 10.1136/jclinpath-2016-203810
  2. Nayak K, Misra M. A review on recent drug delivery systems for posterior segment of eye. Biomed Pharmacother. 2018;107: 1564–1582. doi: 10.1016/j.biopha.2018.08.138
  3. Kemeny-Beke A, Szodoray P. Ocular manifestations of rheumatic diseases. Int Ophthalmol. 2020;40(2):503–510. doi: 10.1007/s10792-019-01183-9
  4. Kötter I., Stübiger N., Deuter C. Ocular involvement in rheumatoid arthritis, connective tissue diseases and vasculitis. Z Rheumatol. 2017;76(8):673–681. doi: 10.1007/s00393-017-0372-7 (In Ger.)
  5. Caimmi C, Crowson CS, Smith WM, et al. Clinical Correlates, Outcomes, and Predictors of Inflammatory Ocular Disease Associated with Rheumatoid Arthritis in the Biologic Era. J Rheumatol. 2018;45(5):595–603. doi: 10.3899/jrheum.170437
  6. Abd-Allah NM, Hassan AA, Omar G, et al. Dry eye in rheumatoid arthritis: relation to disease activity. Immunol Med. 2020;43(2): 92–97. doi: 10.1080/25785826.2020.1729597
  7. Rentka A, Nagy A, Harsfalvi J, et al. Association between objective signs and subjective symptoms of dry eye disease in patients with systemic sclerosis. Rheumatol Int. 2017;37(11):1835–1845. doi: 10.1007/s00296-017-3794-2
  8. Rassi DM, De Paiva CS, Dias LC, et al. Review: MicroRNAS in ocular surface and dry eye diseases. Ocul Surf. 2017;15(4):660–669. doi: 10.1016/j.jtos.2017.05.007
  9. Kuklinski E, Asbell PA. Sjogren’s syndrome from the perspective of ophthalmology. Clin Immunol. 2017;182:55–61. doi: 10.1016/j.clim.2017.04.017
  10. Şahin M, Yüksel H, Şahin A, et al. Evaluation of the Anterior Segment Parameters of the Patients with Scleroderma. Ocul Immunol Inflamm. 2017;25(2):233–238. doi: 10.3109/09273948.2015.1115079
  11. Mayali H, Altinisik M, Sencan S, et al. A multimodal ophthalmic analysis in patients with systemic sclerosis using ocular response analyzer, corneal topography and specular microscopy. Int Ophthalmol. 2020;40(2):287–296. doi: 10.1007/s10792-019-01173-x
  12. Cao Y, Zhang W, Wu J, et al. Peripheral Ulcerative Keratitis Associated with Autoimmune Disease: Pathogenesis and Treatment. J Ophthalmol. 2017;2017:7298026. doi: 10.1155/2017/7298026
  13. Watanabe R, Ishii T, Yoshida M, et al. Ulcerative keratitis in patients with rheumatoid arthritis in the modern biologic era: a series of eight cases and literature review. Int J Rheum Dis. 2017;20(2):225–230. doi: 10.1111/1756-185X.12688
  14. Timlin HM, Hall HN, Foot B, Koay P. Corneal perforation from peripheral ulcerative keratopathy in patients with rheumatoid arthritis: epidemiological findings of the British Ophthalmological Surveillance Unit. Br J Ophthalmol. 2018;102(9):1298–1302. doi: 10.1136/bjophthalmol-2017-310671
  15. Héron E, Bourcier T. Scleritis and episcleritis. J Fr Ophtalmol. 2017;40(8):681–695. doi: 10.1016/j.jfo.2017.04.007
  16. Bielefeld P, Saadoun D, Héron E, et al. Scleritis and systemic diseases: What should know the internist? Rev Med Interne. 2018;39(9):711–720. doi: 10.1016/j.revmed.2018.02.001 (In Fran.)
  17. Yoshida A, Watanabe M, Okubo A, Kawashima H. Clinical characteristics of scleritis patients with emphasized comparison of associated systemic diseases (anti-neutrophil cytoplasmic antibody-associated vasculitis and rheumatoid arthritis). Jpn J Ophthalmol. 2019;63(5):417–424. doi: 10.1007/s10384-019-00674-7
  18. Nevares A, Raut R, Libman B, Hajj-Ali R. Noninfectious Autoimmune Scleritis: Recognition, Systemic Associations, and Therapy. Curr Rheumatol Rep. 2020;22(4):11. doi: 10.1007/s11926-020-0885-y
  19. Clavel G, Gabison E, Semerano L. Corneal and scleral involvement in inflammatory rheumatic disease: Rheumatologists and ophthalmologists exchanging views. Joint Bone Spine. 2019;86(6):699–705. doi: 10.1016/j.jbspin.2019.01.014
  20. Szepessy Z, Barsi Á, Kránitz K, Nagy ZZ. The Evolution of Central Retinal and Choroidal Thickness in Acute Anterior Uveitic Patients with Spondyloarthropathy. J Ophthalmol. 2018;2018:9136017. doi: 10.1155/2018/9136017
  21. Ferreira CS, Beato J, Falcão MS, et al. Choroidal thickness in multisystemic autoimmune diseases without ophthalmologic manifestations. Retina. 2017;37(3):529–535. doi: 10.1097/IAE.0000000000001193
  22. Tetikoglu M, Temizturk F, Sagdik HM, et al. Evaluation of the Choroid, Fovea, and Retinal Nerve Fiber Layer in Patients with Rheumatoid Arthritis. Ocul Immunol Inflamm. 2017;25(2):210–214. doi: 10.3109/09273948.2015.1095303
  23. Kurt A, Kurt EE, Kilic R, et al. Is choroidal thickness related with disease activity and joint damage in patient with rheumatoid arthritis. Bratisl Lek Listy. 2017;118(1):23–27. doi: 10.4149/BLL_2017_005
  24. Ten Berge JC, Schreurs MWJ, van Daele PLA, Rothova A. Autoimmunity in uveitis. Acta Ophthalmol. 2018;96(5):481–485. doi: 10.1111/aos.13652
  25. D’Ambrosio EM, La Cava M, Tortorella P, et al. Clinical Features and Complications of the HLA-B27-associated Acute Anterior Uveitis: A Metanalysis. Semin Ophthalmol. 2017;32(6):689–701. doi: 10.3109/08820538.2016.1170158
  26. Barut K, Adrovic A, Şahin S, Kasapçopur Ö. Juvenile Idiopathic Arthritis. Balkan Med J. 2017;34(2):90–101. doi: 10.4274/balkanmedj.2017.0111
  27. Hayworth JL, Turk MA, Nevskaya T, Pope JE. The frequency of uveitis in patients with juvenile inflammatory rheumatic diseases. Joint Bone Spine. 2019;86(6):685–690. doi: 10.1016/j.jbspin.2019.06.001
  28. Celis R, Cuervo A, Ramírez J, Cañete JD. Psoriatic Synovitis: Singularity and Potential Clinical Implications. Front Med (Lausanne). 2019;6:14. doi: 10.3389/fmed.2019.00014
  29. Cantini F, Niccoli L, Nannini C, et al. Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Semin Arthritis Rheum. 2017;47(2):183–192. doi: 10.1016/j.semarthrit.2017.03.008
  30. Duica I, Voinea LM, Mitulescu C, et al. The use of biologic therapies in uveitis. Rom J Ophthalmol. 2018;62(2):105–113.
  31. Turk MA, Hayworth JL, Nevskaya T, Pope JE. Ocular manifestations in rheumatoid arthritis, connective tissue disease and vasculitis: a systematic review and meta-analysis. [published online ahead of print, 2020 May 1] J Rheumatol. 2021:48(1):25–34. doi: 10.3899/jrheum.190768
  32. Accorinti M, Okada AA, Smith JR, Gilardi M. Epidemiology of Macular Edema in Uveitis. Ocul Immunol Inflamm. 2019;27(2): 169–180. doi: 10.1080/09273948.2019.1576910
  33. Aydin E, Atik S, Koc F, et al. Choroidal and central foveal thickness in patients with scleroderma and its systemic associations. Clin Exp Optom. 2017;100(6):656–662. doi: 10.1111/cxo.12498
  34. Gascon P, Jarrot PA, Matonti F, Kaplanski G. Retinal vasculitis and systemic diseases. Rev Med Interne. 2018;39(9):721–727. doi: 10.1016/j.revmed.2018.04.013
  35. Häuser W, Fitzcharles MA. Facts and myths pertaining to fibromyalgia. Dialogues Clin Neurosci. 2018;20(1):53–62. doi: 10.31887/DCNS.2018.20.1/whauser
  36. Adiguzel S, Palamar M, Yargucu F, et al. Evaluation of Ocular Surface and Meibomian Glands in Patients With Scleroderma. Cornea. doi: 10.1097/ICO.0000000000002551
  37. Szucs G, Szekanecz Z, Aszalos Z, et al. A Wide Spectrum of Ocular Manifestations Signify Patients with Systemic Sclerosis. Ocul Immunol Inflamm. 2021;29(1):81–89. doi: 10.1080/09273948.2019.1657467

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2021 Karpova D.A., Savina E.E., Ponomareva M.N., Lushpaeva Y.A., Partikeeva I.M.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-65574 от 04 мая 2016 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies